[Federal Register Volume 77, Number 134 (Thursday, July 12, 2012)]
[Notices]
[Page 41190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-17002]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number NIOSH-190]


Revised Document Posted: NIOSH List of Antineoplastic and Other 
Hazardous Drugs in Healthcare Settings 2012, Correction

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: A notice of issuance of Final Guidance Publication was 
published in the Federal Register June 27, 2012, (77 FR 38297). This 
notice is corrected as follows:

-----------------------------------------------------------------------

    On page 38297, the Docket number has been changed to NIOSH-190.

FOR FURTHER INFORMATION CONTACT: Barbara MacKenzie, NIOSH, Robert A. 
Taft Laboratories, 4676 Columbia Parkway, MS-C26, Cincinnati, OH 45226, 
Telephone (513) 533-8132, email [email protected].

    Dated: July 6, 2012.
John Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2012-17002 Filed 7-11-12; 8:45 am]
BILLING CODE 4163-19-P